P
uberty is a complex process involving the activation and maturation of the hypothalamic-pituitary-gonadal axis. The mean age of pubertal onset has declined in recent decades; currently, it is 10 y in girls and 11.5-12 y in boys (1) . Normal puberty onset ranges from 8 to 13 y in girls and 9 to 14 y in boys (2) . Precocious puberty is defined as the appearance of the initial signs of sexual maturation-breast buds in girls and testicular volume greater than 3-4 ml in boys-at an age that is more than 2-2.5 SDs below the mean of the population. During the past few decades, the age limit for precocious puberty has been <8 y for girls and 9 y for boys (3) . This definition is somewhat arbitrary because of the marked variation in the age at which puberty begins in healthy children, particularly in different ethnic groups. Precocious puberty is classified as central (gonadotropin-releasing hormone-dependent; GnRH dependent) or peripheral (GnRH independent). Central precocious puberty (CPP) accounts for 80% of patients with precocious puberty and is more frequent in girls than in boys. Incidence of CPP ranges from <0.05 to 0.4% (4) to approximately 1% in China (5) . Early onset of puberty may be caused by a lesion in the central nervous system (6) , so patients with early pubertal onset should be evaluated for the possibility of a central nervous system lesion. Early menarche may increase the risk of breast cancer (7) . On the basis of worldwide studies, pubertal onset seems to be influenced by race, ethnicity, environmental conditions, geographic location, and nutrition (8) . Kaprio et al. conclude that onset age of puberty is affected by environmental agents, which contribute to 26% of variation, and by genetic differences (74% of variation) (9) . Polymorphisms of genes that modulate pubertal onset are hotly pursued topics.
Puberty and infancy are two main periods of accelerated linear growth. Pubertal growth spurt results mainly from the synergistic effects of significantly higher levels of gonadal sex steroids, growth hormone (GH), and insulin growth factor-1 (IGF-1) during this period (2) . A polymorphism in the IGF-1 receptor gene (GAA1013 to GAG) is significantly associated with early pubarche (10) . Furthermore, a potential effect of SNP3 (rs6214) in the IGF-1 gene on the age at menarche in white women has been reported (11) .
Pubertal growth is also dependent on the quantity and distribution of body fat. Obesity is associated with early onset of puberty (1) . Leptin is a 146-amino-acid protein that plays a major role in fat metabolism. The essential role of leptin in onset of puberty was elucidated by a study of patients with a homozygous mutation in the leptin receptor (12) . They did not undergo puberty and had reduced secretion of GH and thyrotropin (12) . Furthermore, administration of recombinant leptin to patients with human congenital leptin deficiency induced the onset of puberty (13) . Leptin also acts as a skeletal bone growth factor. Leptin levels increase just before the onset of puberty and may induce augmented proliferation and differentiation of chondrocytes in the epiphyseal growth plate. Leptin exerts its effect by stimulating IGF-1 receptor gene expression and abundance in the growth center. Although leptin may act on bone independently of GH, it possibly exerts a synergistic effect with the GH/IGF-1 axis (14) . Because leptin concentrations are associated with body weight and body mass index (BMI) in a CPP population (15), we hypothesized that differences in leptin responsiveness may affect the age of pubertal onset. Previous groups have shown that single-nucleotide polymorphisms (SNPs) of the leptin Articles Su et al.
receptor at K109R and Q223R were associated with bone mineral density in a Korean population (16) . An SNP (G>A variant) in the promoter region of the leptin gene at nt-2548 is associated with higher leptin levels in obese girls (17) and extreme obesity in overweight Europeans and Taiwanese aborigines (18) . On the basis of these associations, we hypothesized that the frequency of the G>A variant in the leptin promoter at nt-2548 (rs7799039) or the SNPs in the leptin receptor Q223R (rs1137101) or K109R (rs1137100) may be more frequent in girls with CPP. To test this hypothesis, we conducted a case-control study of 249 CPP cases and 219 controls and examined the association of three common genetic variants in leptin and leptin receptor genes with anthropometric measures, precocious puberty risk, and concentrations of circulating leptin, hormones (estradiol (E 2 ), follicle-stimulating hormone (FSH), luteinizing hormone (LH)), and fat (cholesterol and triglyceride (TG)).
ReSUlTS
The demographics of 249 girls who had early breast development (<8 y) and were diagnosed with CPP were compared with 219 girls in the control group (peak LH levels <7 U/l for all controls). Among the 249 girls with CPP, there were 134 girls in Tanner stage II and 115 girls in Tanner stage III; whereas among the 219 control girls, 90 girls were in Tanner stage I and 129 girls were in Tanner stage II. As shown in Table 1 , the CPP group exhibited significantly higher bone age (BA), BA/chronological age (CA), height, weight, BMI, and levels of several sex hormones (E2, FSH, and LH) than the control group, but the CA showed no significant differences between the two groups. In addition, leptin expression in the CPP group was 7.6 ng/ml (SD = 5.7), whereas leptin expression in the control group was 6.2 ng/ml (SD = 5.4) (P < 0.01; Table 1 ). Thus, leptin expression was significantly higher in the CPP group as compared with the control group.
We next analyzed whether a significantly higher level of leptin in patients with CPP correlated with the early onset of puberty. Because BMI and leptin levels are higher in the CPP group and BMI may act as a confounding factor, the correlation of leptin with relative demographics and clinical pathologic features by group and the overall population were adjusted for BMI as a covariate. These represented partial correlations ( Table 2 ). In the overall population, height, weight, BMI, and serum level of TG were significantly and directly correlated with leptin levels. Similarly, height, weight, and BMI, but not TG levels, were correlated with leptin in the control group. The CPP group showed no significant correlation between leptin and demographic features (height, weight, BMI, and sex hormones) but showed a positive correlation between serum levels of TGs and leptin levels. Table 3 shows the distribution of genotypes of SNPs at LEP −2548, LEPR 109, and LEPR 203 in the CPP and control groups. The distribution of A/A, A/G, or G/G for the SNPs at LEP −2548, LEPR 109, and LEPR 203 in the CPP group was not significantly different from that in the control group. No significant differences were detected in the distribution between A/A and non-A/A (A/G or G/G) in the two groups. The distribution of the A and G alleles at leptin −2548 in the CPP group was not significantly different from that in the control group.
We subsequently investigated whether various combinations of LEP −2548 plus LEPR 223 polymorphisms and combinations of LEP −2548 plus LEPR 109 polymorphisms were associated with CPP phenotype. We compared the demographics and pathologic features with the prevalence of three combinations of LEP −2548 and LEPR 223 SNPs, and three combinations of LEP −2548 and LEPR 109 SNPs, in the CPP and control groups separately, which would avoid confounding effects of the significantly different values ( Table 4) . No significant difference was found in demographics and pathologic features among the girls diagnosed with CPP with different combinations of SNPs at LEP promoter −2548 plus LEPR 223 or LEP promoter −2548 plus LEPR 109 (Table 4) . However, significant differences in mean LH levels were observed among control girls with different combinations of SNPs: LEP promoter −2548 plus LEPR 223 (P = 0.002) and LEP promoter −2548 plus LEPR 109 (P = 0.003) ( Table 4) . Furthermore, control girls with LEP −2548A/A and LEPR 223 A/G alleles had significantly higher LH levels (P = 0.002) than those with LEP −2548A/G and LEPR 223 G/G ( Table 4) .
Demographics and pathologic features of CPP were compared in both CPP and control groups among three genotypes of LEPR 223 SNP and three genotypes of LEPR 109 SNP ( Table 5) . Demographics and pathologic features of the CPP group did not significantly associate with any specific genotype of LEPR 223 SNP or LEPR 109 SNP ( Table 5) . Analysis of the control group suggested significant associations between specific genotypes at LEPR SNPs and mean FSH levels or mean LH levels. Significant differences were found in mean FSH levels among the control girls with Articles Leptin in central precocious puberty different genotypes at LEPR 223 (P = 0.03). In addition, significant differences were detected in mean LH levels among the control girls with different genotypes at LEPR 223 (P = 0.01) and LEPR 109 (P = 0.004).
DISCUSSIon
A recent meta-analysis of genome-wide association studies identified 30 new loci associated with age of menarche (19) . Four genes were associated with BMI, three with energy homeostasis, and three with regulation of hormones (19) . Su et al. (15) proposed that leptin concentrations are associated with body weight and BMI in a CPP population. In addition, genetic regulation of pubertal (GRP) onset most likely arises from multiple genes that are critical for the pubertal activation of the hypothalamic-pituitary axis. Genes involved in regulating puberty are being identified by their association with abnormal genetic pubertal development and include the GnRH receptor gene (20) , GRP54 receptor gene (21), estrogen gene (2), FSH gene (22) , LH gene (23) , LEP gene (24), and LEPR gene (12) . Thus, our study hypothesizes that the polymorphisms in LEP and LEPR genes may correlate with the variant phenotypes of patients with CPP. However, our thorough analyses suggest that specific alleles at these SNPs of LEP or LEPR 223 and 109 were not significantly associated with CPP.
Our results indicated that leptin levels in the CPP group positively correlated with both BMI and TG. It is reasonable because it has been well documented that BMI has a positive association with the serum TG levels (25, 26) . In the control group, leptin levels significantly correlated with height, weight, and BMI but did not correlate with TG levels. Our study found that leptin levels were significantly higher in the CPP group than in the control group, which may partially explain the higher BMI in girls with CPP.
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and LEPR polymorphism Q223R (17, 27) . Higher leptin levels in the CPP group might also associate with SNPs in the LEP promoter (G-2548A) and/or the LEPR genes. SNP analysis of the CPP and control groups showed that the distribution of the A/A, A/G, and G/G alleles at LEP −2548, LEPR 109, and LEPR 223 were not significantly different. The two groups showed no distinct disparities in the frequencies of A/A and non-A/A (A/G, G/G) genotypes. The distribution of As and Gs at LEP −2548 also did not differ significantly between the two groups. These data suggest that disparities at each individual SNP were not sufficient to explain the higher leptin levels among girls with CPP. Specific combinations of LEP and LEPR polymorphisms may associate with a certain abnormality of the human body. For example, the combination of LEP (G-2548A) and LEPR polymorphism Q223R significantly increased the risk for oral cancer (28) . We subsequently investigated whether various combinations of LEP −2548 plus LEPR 223 polymorphisms and combinations of LEP −2548 plus LEPR 109 polymorphisms were associated with CPP phenotype. We found no significant difference in demographics and pathologic features among the girls with CPP with different combinations of SNPs at LEP promoter −2548 plus LEPR 223 or LEP promoter −2548 plus LEPR 109. We then compared the demographics and pathologic features of CPP in both the CPP and control groups among three genotypes of LEPR 223 and three genotypes of LEPR 109. The results also showed that demographics and pathologic features among the girls with CPP were not significantly associated with any specific genotype of LEPR 223 or LEPR 109. These observations failed to support our original hypothesis. However, our findings were consistent with the reports of genome-wide association studies that there was a lack of association of age of menarche with SNPs in the LEP promoter or LEPR (19) . Data were presented as mean ± sD, and compared using one-way ANOVA with Bonferroni multiple comparisons. BA/cA, bone age/chronological age; cPP, central precocious puberty; e2, estradiol; Fsh, follicle-stimulating hormone; Lh, luteinizing hormone. 
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However, for the control girls, there were significant differences in mean LH levels among girls with different combinations of SNPs at the LEP promoter −2548 plus LEPR 223 and the LEP promoter −2548 plus LEPR 109. Furthermore, there were significant differences in mean FSH and mean LH levels among the control girls with different genotypes at LEPR 223, and in mean LH levels among the control girls with different genotypes at LEPR 109. Because there were no differences in the leptin levels between the three genotypes, leptin might not directly affect the hormone levels in control girls. Instead, polymorphisms in the leptin receptor gene seem to affect critical elements in the FSH and LH synthesis pathway. These potential mechanisms warrant further study.
In conclusion, none of the alleles at the three SNPs in this study or combinations of two SNPs were significantly associated with demographics and pathologic features in girls with CPP. However, control group individuals with the genotype LEP promoter −2548 A/A and LEPR 223 A/G combination exhibited higher LH levels than individuals with LEP promoter −2548 A/A and LEPR 223 G/G combination. Comparative analysis showed that the control group individuals with A/G at LEPR 223 exhibited significantly higher peak LH and FSH levels and control group individuals with A/G at LEPR 109 exhibited significantly higher peak LH levels. The associations between FSH and LH levels and SNPs at both LEPR 223 and LEPR 109 warrant further investigation in the general population.
MeTHoDS
Subjects
A group of 249 girls with progressive breast development and early puberty (onset before 8 y of age) and a control group of 219 girls with mild breast development and pubertal onset after 8 y of age were recruited and closely followed up every 3 mo for up to 1 y. Physical examination was performed for all the girls. They had no genetic or systemic diseases, and thyroid and adrenal function was normal. CPP Data were presented as mean ± sD, and compared using one-way ANOVA with Bonferroni multiple comparisons. BA/cA, bone age/chronological age; cPP, central precocious puberty; e2, estradiol; Fsh, follicle-stimulating hormone; Lh, luteinizing hormone. *P < 0.05, significantly different among three types of genotypes from one-way ANOVA.
